These data suggest that estrogen attenuates heart failure in the presence of perturbed cardiac insulin signaling and provides a mechanism for the gender difference in the prevalence of cardiovascular disease and type 2 diabetes. The gene discussed is INS; the disease is cardiovascular disorder.